Age Ayurveda Nighantu

Kalonji

Nigella sativa

Kalonji (Nigella sativa) is a plant used in Ayurveda, from the Ranunculaceae family. Listed in the Pharmacopoeia of India at recommended dose of 0.5-4 g seed powder for digestive and carminative purposes.

Key facts
Botanical nameNigella sativa
FamilyRanunculaceae · other entries in this family
OrderRanunculales
Pharmacopoeia statusListed in the Pharmacopoeia of India at recommended dose of 0.5-4 g seed powder for digestive and carminative purposes. Recognized in Unani medicine (Tibb-e-Nabawi) and traditional Islamic medicine with extensive historical documentation. Not yet included in WHO monographs as a standalone entry, though substantial peer-reviewed evidence supports therapeutic applications.
Taxon identifiersGBIF 5371700 · Wikidata Q160575 · NCBI Taxonomy 555479

This entry and kalajaji describe the same drug, Nigella sativa, under different names. Both pages are kept because both names are in use; the other is treated as the primary record for citation.

Names and identification

LanguageName
EnglishKalonji
Latin/BotanicalNigella sativa

Key Phytochemical Constituents

How does it work?

  • Thymoquinone inhibits NF-kB, MAPK, and JAK/STAT signaling pathways, suppressing pro-inflammatory cytokine production
  • Anti-asthmatic action through functional antagonism of muscarinic receptors, inhibition of histamine H1 receptors, calcium channel blocking, potassium channel opening, and beta-adrenergic receptor stimulation
  • Anticancer activity via induction of apoptosis through mitochondrial pathway, cell cycle arrest, and inhibition of angiogenesis
  • Antidiabetic mechanism through enhanced pancreatic beta-cell function, improved insulin sensitivity, and inhibition of hepatic gluconeogenesis
  • Antimicrobial action through oxidative stress-induced cell apoptosis, efflux pump blockade, and enhanced membrane permeability in pathogens

Which traditional uses are supported by research?

  • Digestive aid and carminative for bowel and indigestion problems - validated by pharmacological studies confirming antispasmodic and carminative effects
  • Anti-asthmatic and respiratory relief - validated by clinical trials showing bronchodilatory effects and improved lung function in asthma patients
  • Blood sugar control in diabetes - supported by year-long adjuvant clinical trial (114 patients, 2 g/day) showing improved glycemic control in type 2 diabetes
  • Lipid-lowering and cardiovascular protection - confirmed by meta-analyses showing significant improvements in lipid profiles
  • Immune modulation and anti-infective use - validated by immunological studies demonstrating enhanced immune cell function and antimicrobial activity

What do recent clinical trials show?

1 further claim previously listed here could not be traced to a published paper and has been removed. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Phase I study established safe daily thymoquinone dosage below 48.6 mg per adult (based on NOAEL of 5 mg/kg in 90-day rat studies, converted to human equivalent dose)
  • Very low toxicity profile; two cases of contact dermatitis reported with topical use; no significant adverse effects on liver or kidney function with oral administration of seed extract or oil
  • Caution advised with concurrent use of antidiabetic, antihypertensive, and immunosuppressive drugs due to potential synergistic effects; not recommended during pregnancy without medical supervision

What is it made of?

Key Active Markers

  • Thymoquinone
  • Thymohydroquinone
  • Thymol
  • Carvacrol
  • Nigellidine
  • Alkaloids
  • Nigellicine and

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Seed (whole), Churna (seed powder), Taila (seed oil), Capsule, Soft gel capsule, Tablet

Standard Dosage: 1-3g whole seeds daily; 2.5-5ml oil daily; 500mg-1g extract; commonly mixed with honey (1 tsp seeds + 1 tsp honey)

Bioavailability: Nigella sativa (Kalonji is the Hindi/Urdu name, same as Kalajaji). Thymoquinone bioavailability ~58% in animal models. The oil form serves as a natural self-emulsifying delivery system, providing superior TQ absorption compared to powder form. Nigella oil taken with food shows 2-3x higher TQ plasma levels than fasted state. SNEDDS and nanoparticle formulations under active research for enhanced delivery.

Optimal Timing: Morning on empty stomach with honey (traditional); with meals for digestive support; oil with fatty meal for enhanced absorption

Standardized Extract: Cold-pressed seed oil (thymoquinone >0.8%); CO2 extract (thymoquinone 3-5%); aqueous-ethanolic extract standardized to 2% thymoquinone

Shelf Life: 3 years (whole seeds); 1-2 years (oil); 1 year (powder); 3 years (soft gel/capsule)

Storage: Seeds: cool, dry, airtight containers. Oil: amber glass, nitrogen-flushed, below 25°C. Protect from light and heat. Avoid plastic containers for oil storage.

Marker Compounds: Thymoquinone, Thymohydroquinone, Thymol, Carvacrol, Nigellone, p-Cymene, Alpha-hederin, Nigellidine, Nigellicine

Extraction Methods

  • Cold pressing (seed oil, 30-40% yield)
  • Supercritical CO2 extraction
  • Steam distillation (essential oil)
  • Hydroalcoholic extraction for polyphenol-enriched extract
  • Traditional honey infusion

Synergistic Combinations

  • With Honey for immune support (Prophetic medicine tradition)
  • With Haridra for systemic anti-inflammatory action
  • With Ajwain for digestive support
  • With Methi seeds for metabolic syndrome management

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Systematic reviews and meta-analyses1

  1. Li Z, Wang Y, Xu Q and others. 2023. Nigella sativa and health outcomes: An overview of systematic reviews and meta-analysesFrontiers in nutrition. PMID 37057067 · doi:10.3389/fnut.2023.1107750

Other clinical studies and reviews11

  1. Alberts A, Moldoveanu ET, Niculescu AG and others. 2024. Nigella sativa: A Comprehensive Review of Its Therapeutic Potential, Pharmacological Properties, and Clinical ApplicationsInternational journal of molecular sciences. PMID 39769174 · doi:10.3390/ijms252413410
  2. Wahab S, Alsayari A. 2023. Potential Pharmacological Applications of Nigella Seeds with a Focus on Nigella sativa and Its Constituents against Chronic Inflammatory Diseases: Progress and Future OpportunitiesPlants (Basel, Switzerland). PMID 38005726 · doi:10.3390/plants12223829
  3. Ciesielska-Figlon K, Wojciechowicz K, Wardowska A and others. 2023. The Immunomodulatory Effect of Nigella sativaAntioxidants (Basel, Switzerland). PMID 37507880 · doi:10.3390/antiox12071340
  4. Ferizi R, Ramadan MF, Maxhuni Q. 2023. Black Seeds (Nigella sativa) Medical Application and Pharmaceutical PerspectivesJournal of pharmacy & bioallied sciences. PMID 37469646 · doi:10.4103/jpbs.jpbs_364_22
  5. Hadi V, Pahlavani N, Malekahmadi M and others. 2021. Nigella sativa in controlling Type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: Molecular aspectsJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. PMID 34221050 · doi:10.4103/jrms.JRMS_236_20
  6. Dalli M, Bekkouch O, Azizi SE and others. 2021. Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019-2021)Biomolecules. PMID 35053168 · doi:10.3390/biom12010020
  7. Mashayekhi-Sardoo H, Rezaee R, Karimi G. 2020. Nigella sativa (black seed) safety: an overviewAsian biomedicine : research, reviews and news. PMID 37551386 · doi:10.1515/abm-2020-0020
  8. Mekhemar M, Hassan Y, Dörfer C. 2020. Nigella sativa and Thymoquinone: A Natural Blessing for Periodontal TherapyAntioxidants (Basel, Switzerland). PMID 33322636 · doi:10.3390/antiox9121260
  9. Eid AM, Elmarzugi NA, Abu Ayyash LM and others. 2017. A Review on the Cosmeceutical and External Applications of Nigella sativaJournal of tropical medicine. PMID 29358959 · doi:10.1155/2017/7092514
  10. Beheshti F, Khazaei M, Hosseini M. 2016. Neuropharmacological effects of Nigella sativaAvicenna journal of phytomedicine. PMID 27247928
  11. Hayatdavoudi P, Khajavi Rad A, Rajaei Z and others. 2016. Renal injury, nephrolithiasis and Nigella sativa: A mini reviewAvicenna journal of phytomedicine. PMID 27247917

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.